Impax Asset Management Group
RMD icon

Impax Asset Management Group’s ResMed RMD Stock Holding History

Impax Asset Management Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Hold
7,081
– – 0.01% 281
2026
Q1 		$1.59M Buy
7,081
+3,212
+83% +$800K 0.01% 274
2025
Q4 		$932K Hold
3,869
– – 0.01% 279
2025
Q3 		$1.06M Buy
+3,869
New +$1.06M 0.01% 267

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Impax Asset Management Group's RMD Position: Q2 2026 in Review

Impax Asset Management Group held its ResMed (RMD) position steady in Q2 2026 at 7,081 shares worth $1.38M. The position accounts for 0.01% of the portfolio, ranked #281.

Impax Asset Management Group first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.59M in Q1 2026. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Impax Asset Management Group held 7,081 shares of ResMed worth $1.38M as of Q2 2026.
  • Impax Asset Management Group left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.01% of Impax Asset Management Group's portfolio in Q2 2026, its #281 holding.
  • Impax Asset Management Group first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
  • Impax Asset Management Group's ResMed position peaked at $1.59M in Q1 2026.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.